HelloMD Telemedicine Services Now Available to New York Medical Cannabis Patients

HelloMD Brings Successful Online Marijuana Doctor Service to New York

Nation’s leading medical marijuana telemedicine provider, community and marketplace, announces roll-out beyond CA

SAN FRANCISCO, June 15, 2017 /PRNewswire/ — HelloMD, the nation’s largest community of medical cannabis patients, experts and trusted brands, announced that its telemedicine services will be available throughout New York State effective today. This marks the first major expansion of the company’s telemedicine services outside of its home base of California. New York’s medical cannabis program considers telemedicine visits as valid patient-provider engagements, allowing certified providers to prescribe cannabis-based medicine through this highly efficient mode of doctor-patient consults.

The state of New York has experienced growing pains since opening its program to patients in January 2016. However, with the recent addition of chronic pain to the list of qualifying conditions and a growing supply of certified Doctors, Nurse Practitioners and Registered Nurses, the program has seen a spike in demand. Other qualifying conditions in New York include cancer, HIV, ALS, Multiple Sclerosis, epilepsy, inflammatory bowel disease, neuropathies, and Huntington’s disease.

The state of New York approved medical marijuana use in 2014, and subsequently passed the New York Telehealth Amendment Act in 2015, but there is still exceptionally limited telemedicine and medical marijuana access presently in New York. With the extension of HelloMD’s services into New York State, we are providing enhanced patient access and experience with highly qualified physicians to all New Yorker’s with a qualifying condition, all within the comfort and privacy of the patient’s home.

Mark Hadfield, Co-Founder and CEO of HelloMD

HelloMD recently announced the launch of their Product Marketplace, a highly-scalable, retail destination that will allow the 150,000+ members of its health & wellness community to learn about and place orders for medical cannabis products from leading retailers. This new functionality adds to an already robust feature set that enables cannabis patients to connect with doctors, experts and trusted brands, to uncover the right cannabis solution for them.

This announcement also comes on the heels of HelloMD’s crowdfunding campaign launch with SeedInvest, opening an investment opportunity in the company to any and all interested parties.

About HelloMD

HelloMD is one of the nation’s largest online community of medical cannabis patients, experts, brands and trusted retailers, offering today’s cannabis patient a full turnkey experience. At HelloMD.com medical cannabis consumers can consult with a doctor via real-time video, obtain answers to questions from a network of doctors and experts, as well as research then buy cannabis products from within the HelloMD Marketplace. For more information about HelloMD, or to join its growing member community, visit www.hellomd.com or follow us on Facebook (@HelloMDcompany) and Twitter (@HelloMD_com).

Original press release: http://www.prnewswire.com/news-releases/hellomd-brings-successful-online-marijuana-doctor-service-to-new-york-300474576.html

Published by NCV Newswire

The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. For questions contact us.

Latest News
Get The App

Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get real-time push notifications straight to your phone on the latest breaking news and exclusives published.


ncv-news-ios-app-store

ncv-news-google-play

NCV Media

Thank you for reading

New Cannabis Ventures

Contributing original content and curating quality news on only the most promising cannabis companies and the most influential investors.

FOLLOW US ON